Literature DB >> 15753434

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment.

K Kantarci1, R C Petersen, B F Boeve, D S Knopman, S D Weigand, P C O'Brien, M M Shiung, G E Smith, R J Ivnik, E G Tangalos, C R Jack.   

Abstract

The authors assessed whether measures of hippocampal water diffusivity at baseline can predict future progression to Alzheimer disease (AD) in amnestic mild cognitive impairment (aMCI). Higher baseline hippocampal diffusivity was associated with a greater risk of progression to AD in aMCI (p = 0.002). Magnetic resonance diffusion-weighted imaging may help identify patients with aMCI who will progress to AD as well as or better than structural MRI measures of hippocampal atrophy.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15753434      PMCID： PMC2771335          DOI： 10.1212/01.WNL.0000153076.46126.E9

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  8 in total

1.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

Authors:  K Kantarci; C R Jack; Y C Xu; N G Campeau; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E Kokmen; E G Tangalos; R C Petersen
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease.

Authors:  H Hanyu; H Sakurai; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  J Neurol Sci       Date:  1998-04-01       Impact factor: 3.181

3.  MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies.

Authors:  C R Jack; M D Bentley; C K Twomey; A R Zinsmeister
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

4.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

Review 5.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

6.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

7.  Diffusion-weighted magnetic resonance imaging in Alzheimer's disease.

Authors:  T A Sandson; O Felician; R R Edelman; S Warach
Journal:  Dement Geriatr Cogn Disord       Date:  1999 Mar-Apr       Impact factor: 2.959

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910
  8 in total
  72 in total

Review 1.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Fractional anisotropy derived from the diffusion tensor distribution function boosts power to detect Alzheimer's disease deficits.

Authors:  Talia M Nir; Neda Jahanshad; Julio E Villalon-Reina; Dmitry Isaev; Artemis Zavaliangos-Petropulu; Liang Zhan; Alex D Leow; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Magn Reson Med       Date:  2017-03-07       Impact factor: 4.668

3.  Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.

Authors:  Michelle M Mielke; Ozioma C Okonkwo; Kenichi Oishi; Susumu Mori; Sarah Tighe; Michael I Miller; Can Ceritoglu; Timothy Brown; Marilyn Albert; Constantine G Lyketsos
Journal:  Alzheimers Dement       Date:  2012       Impact factor: 21.566

4.  Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.

Authors:  Elisa Canu; Donald G McLaren; Michele E Fitzgerald; Barbara B Bendlin; Giada Zoccatelli; Franco Alessandrini; Francesca B Pizzini; Giuseppe K Ricciardi; Alberto Beltramello; Sterling C Johnson; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Education mediates microstructural changes in bilateral hippocampus.

Authors:  Fabrizio Piras; Andrea Cherubini; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Hum Brain Mapp       Date:  2011-02       Impact factor: 5.038

6.  Impact of KIBRA Polymorphism on Memory Function and the Hippocampus in Older Adults.

Authors:  A Veronica Witte; Theresa Köbe; Lucia Kerti; Dan Rujescu; Agnes Flöel
Journal:  Neuropsychopharmacology       Date:  2015-07-09       Impact factor: 7.853

7.  Brain-water diffusion coefficients reflect the severity of inherited prion disease.

Authors:  H Hyare; S Wroe; D Siddique; T Webb; N C Fox; J Stevens; J Collinge; T Yousry; J S Thornton
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

8.  Hydration water mobility is enhanced around tau amyloid fibers.

Authors:  Yann Fichou; Giorgio Schirò; François-Xavier Gallat; Cedric Laguri; Martine Moulin; Jérôme Combet; Michaela Zamponi; Michael Härtlein; Catherine Picart; Estelle Mossou; Hugues Lortat-Jacob; Jacques-Philippe Colletier; Douglas J Tobias; Martin Weik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

9.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

Review 10.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.